SREBP-regulated adipocyte lipogenesis is dependent on substrate availability and redox modulation of mTORC1.

The synthesis of lipid and sterol species through de novo lipogenesis (DNL) is regulated by two functionally overlapping but distinct transcription factors: the sterol regulatory element-binding proteins (SREBPs) and carbohydrate response element binding protein (ChREBP). ChREBP is considered to be the dominant regulator of DNL in adipose tissue (AT); however, the SREBPs are highly expressed and robustly regulated in adipocytes, suggesting that the model of AT DNL may be incomplete. Here we describe a new mouse model of inducible, adipocyte-specific overexpression of the insulin-induced gene 1 (Insig1), a negative regulator of SREBP transcriptional activity. Contrary to convention, Insig1 overexpression did block AT lipogenic gene expression. However, this was immediately met with a compensatory mechanism triggered by redox activation of mTORC1 to restore SREBP1 DNL gene expression. Thus, we demonstrate that SREBP1 activity sustains adipocyte lipogenesis, a conclusion that has been elusive due to the constitutive nature of current mouse models.

[1]  Fajun Yang,et al.  Regulation and Metabolic Significance of De Novo Lipogenesis in Adipose Tissues , 2018, Nutrients.

[2]  Zhijian J. Chen,et al.  BHLHE40, a third transcription factor required for insulin induction of SREBP-1c mRNA in rodent liver , 2018, eLife.

[3]  I. Shimomura,et al.  Oxidative Stress Inhibits Healthy Adipose Expansion Through Suppression of SREBF1-Mediated Lipogenic Pathway , 2018, Diabetes.

[4]  R. Hammer,et al.  Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice[S] , 2018, Journal of Lipid Research.

[5]  Ji Miao,et al.  Fructose and glucose can regulate mammalian target of rapamycin complex 1 and lipogenic gene expression via distinct pathways , 2017, The Journal of Biological Chemistry.

[6]  A. Saghatelian,et al.  Absence of Carbohydrate Response Element Binding Protein in Adipocytes Causes Systemic Insulin Resistance and Impairs Glucose Transport. , 2017, Cell reports.

[7]  Rana K. Gupta,et al.  The expanding problem of adipose depot remodeling and postnatal adipocyte progenitor recruitment , 2017, Molecular and Cellular Endocrinology.

[8]  J. Goldstein,et al.  Insulin induction of SREBP-1c in rodent liver requires LXRα-C/EBPβ complex , 2016, Proceedings of the National Academy of Sciences.

[9]  Christian M. Metallo,et al.  Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism , 2016, Nature Communications.

[10]  L. Chan,et al.  FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance. , 2015, Endocrinology.

[11]  Alexandre Caron,et al.  The Roles of mTOR Complexes in Lipid Metabolism. , 2015, Annual review of nutrition.

[12]  J. Horton,et al.  A high-fat diet suppresses de novo lipogenesis and desaturation but not elongation and triglyceride synthesis in mice[S] , 2014, Journal of Lipid Research.

[13]  F. Zwartkruis,et al.  Rheb and mammalian target of rapamycin in mitochondrial homoeostasis , 2013, Open Biology.

[14]  T. Herbert,et al.  Evidence for Rapamycin Toxicity in Pancreatic β-Cells and a Review of the Underlying Molecular Mechanisms , 2013, Diabetes.

[15]  U. Knippschild,et al.  De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health , 2013, Nature Communications.

[16]  G. Shulman,et al.  Decreased Transcription of ChREBP-α/β Isoforms in Abdominal Subcutaneous Adipose Tissue of Obese Adolescents With Prediabetes or Early Type 2 Diabetes , 2013, Diabetes.

[17]  R. Hammer,et al.  Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase , 2012, Proceedings of the National Academy of Sciences.

[18]  Haowei Song,et al.  Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARγ activation to decrease diet-induced obesity. , 2012, Cell metabolism.

[19]  M. Blüher,et al.  A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism , 2012, Nature.

[20]  X. Bai,et al.  Multi-mechanisms are involved in reactive oxygen species regulation of mTORC1 signaling. , 2010, Cellular signalling.

[21]  P. Scherer,et al.  Identification and characterization of a promoter cassette conferring adipocyte-specific gene expression. , 2010, Endocrinology.

[22]  G. Berry,et al.  Quantification of galactose-1-phosphate uridyltransferase enzyme activity by liquid chromatography-tandem mass spectrometry. , 2010, Clinical chemistry.

[23]  J. Moreno-Navarrete,et al.  The Gene Expression of the Main Lipogenic Enzymes is Downregulated in Visceral Adipose Tissue of Obese Subjects , 2010, Obesity.

[24]  D. Sabatini,et al.  An Emerging Role of mTOR in Lipid Biosynthesis , 2009, Current Biology.

[25]  S. Kawahito,et al.  Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. , 2009, World journal of gastroenterology.

[26]  S. Ryu,et al.  Glycolytic Flux Signals to mTOR through Glyceraldehyde-3-Phosphate Dehydrogenase-Mediated Regulation of Rheb , 2009, Molecular and Cellular Biology.

[27]  Claudio R. Santos,et al.  SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth , 2008, Cell metabolism.

[28]  P. Löfgren,et al.  Impaired subcutaneous adipocyte lipogenesis is associated with systemic insulin resistance and increased apolipoprotein B/AI ratio in men and women , 2007, Journal of internal medicine.

[29]  T. Kadowaki,et al.  SREBP-1-independent regulation of lipogenic gene expression in adipocytes Published, JLR Papers in Press, April 24, 2007. , 2007, Journal of Lipid Research.

[30]  V. Iacobazzi,et al.  Transcription of the mitochondrial citrate carrier gene: role of SREBP-1, upregulation by insulin and downregulation by PUFA. , 2007, Biochemical and biophysical research communications.

[31]  B. Lecka-Czernik,et al.  The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment Published, JLR Papers in Press, August 7, 2006. , 2006, Journal of Lipid Research.

[32]  R. Palmiter,et al.  Modulation of neuropeptide Y expression in adult mice does not affect feeding. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  K. Iizuka,et al.  Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Hammer,et al.  Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. , 2004, The Journal of clinical investigation.

[35]  R. Hammer,et al.  Overexpression of Sterol Regulatory Element-binding Protein-1a in Mouse Adipose Tissue Produces Adipocyte Hypertrophy, Increased Fatty Acid Secretion, and Fatty Liver* , 2003, Journal of Biological Chemistry.

[36]  R. Aebersold,et al.  Crucial Step in Cholesterol Homeostasis Sterols Promote Binding of SCAP to INSIG-1, a Membrane Protein that Facilitates Retention of SREBPs in ER , 2002, Cell.

[37]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[38]  U. G. Jensen,et al.  Neonatal screening for galactosemia by quantitative analysis of hexose monophosphates using tandem mass spectrometry: a retrospective study. , 2001, Clinical chemistry.

[39]  R. Hammer,et al.  SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation. , 2001, Genes & development.

[40]  Jean-Marc A. Lobaccaro,et al.  Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ , 2000 .

[41]  R. Hammer,et al.  Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. , 1998, Genes & development.

[42]  R. Hammer,et al.  Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. , 1997, The Journal of clinical investigation.

[43]  H. Kuriyama,et al.  Compensatory increase in fatty acid synthesis in adipose tissue of mice with conditional deficiency of SCAP in liver. , 2005, Cell metabolism.

[44]  M. Beylot,et al.  Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. , 2002, American journal of physiology. Endocrinology and metabolism.